APTEVO THERAPEUTICS INC (APVO:NASDAQ)
$4.44 0.07 (1.6018%)
Analysed APTEVO THERAPEUTICS INC (APVO:NASDAQ) News Sources
Aptevo Therapeutics (APVO) Upgraded to Buy: Here's Why
10-04-2026
yahoo.com
Aptevo to Participate in March 2026 Conferences
19-03-2026
yahoo.com
Mipletamig Delivers Compelling 86% Clinical Benefit Rate and No CRS as Evaluable AML Patient Data increases by Nearly 50%
10-03-2026
yahoo.com
Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth
03-02-2026
yahoo.com
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality
09-01-2026
yahoo.com
Sector Update: Health Care Stocks Edge Higher Late Afternoon
26-12-2025
yahoo.com
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
26-12-2025
yahoo.com
Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025
09-12-2025
yahoo.com
Aptevo Therapeutics (APVO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
19-11-2025
yahoo.com
Aptevo Debuts First Trispecific Antibody Candidate, APVO451, with Preclinical Data Demonstrating Immune Activation in Hard-to-Treat Solid Tumors
10-11-2025
yahoo.com
What is the current price of APTEVO THERAPEUTICS INC (APVO:NASDAQ)?
The current price of APTEVO THERAPEUTICS INC (APVO:NASDAQ) is $4.44.
APTEVO THERAPEUTICS INC (APVO:NASDAQ) absolute price change since previous trading day?
The absolute price change of APTEVO THERAPEUTICS INC (APVO:NASDAQ) since the previous trading day is $0.07.
APTEVO THERAPEUTICS INC (APVO:NASDAQ) percentage price change since previous trading day?
The percentage price change of APTEVO THERAPEUTICS INC (APVO:NASDAQ) since the previous trading day is 1.6018%.
What is the most recent average sentiment score for APTEVO THERAPEUTICS INC (APVO:NASDAQ)?
The most recent average sentiment score for APTEVO THERAPEUTICS INC (APVO:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for APTEVO THERAPEUTICS INC (APVO:NASDAQ)?
The most recent sentiment for APTEVO THERAPEUTICS INC (APVO:NASDAQ) is .
SEC-8K** Filing Available For APTEVO THERAPEUTICS INC (APVO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.